G McInnes Selected Research

KT3 671

11/2003

The effects of KT3-671, a new angiotensin II (AT 1) receptor blocker in mild to moderate hypertension.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

G McInnes Research Topics

Disease

3	Hypertension (High Blood Pressure) 01/2006 - 01/2001
2	Type 2 Diabetes Mellitus (MODY) 11/2015 - 01/2001
1	Heart Failure 11/2015
1	Stroke (Strokes) 01/2006
1	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 01/2006
1	Essential Hypertension 11/2003
1	Coronary Disease (Coronary Heart Disease) 01/2001

Drug/Important Bio-Agent (IBA)

2	Antihypertensive Agents (Antihypertensives)IBA 11/2003 - 01/2001
1	VildagliptinIBA 11/2015
1	Losartan (Cozaar)FDA LinkGeneric 01/2006
1	Atenolol (Tenormin)FDA LinkGeneric 01/2006
1	KT3 671IBA 11/2003
1	Angiotensin IIIBA 11/2003
1	CholesterolIBA 01/2001
1	Amlodipine (Norvasc)FDA LinkGeneric 01/2001
1	CalciumIBA 01/2001
1	AngiotensinsIBA 01/2001
1	Valsartan (Vals)FDA Link 01/2001

Therapy/Procedure

1	Therapeutics 01/2006